Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
 |
Results for 'Proteomics' |
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
|
Proteomics International Market Trends |
November 2009 | £1980 | 100 % |
|
Proteomics Technologies, Markets and Companies |
March 2010 | £2970 | 100 % |
|
Proteomics: Industry Background Report List of Companies |
October 2005 | £400 | 96 % |
|
Transforming Drug Discovery through Genomics and Proteomics |
January 2009 | £395 | 35 % |
|
Bioinformatics A Practical Guide to the Analysis of Genes and Proteins, 3rd Edition |
November 2004 | £50.95 | 30 % |
|
Handbook of Genome Research Genomics, Proteomics, Metabolomics, Bioinformatics, Ethical and Legal Issues, Two Volumes |
June 2005 | £175 | 29.05 % |
|
Convergence of Biomarkers and Diagnostics, The Therapy Area Analyses, Key Products and Future Trends |
April 2008 | £1995 | 22.75 % |
|
Molecular Diagnostics Technologies, Markets and Companies |
March 2010 | £3300 | 22 % |
|
Commercial Opportunities from Biomarkers Transforming drug discovery, clinical development and molecular diagnostic |
May 2006 | £1495 | 18.55 % |
|
Biotechnology and Biopharmaceuticals Transforming Proteins and Genes into Drugs |
July 2003 | £55.95 | 17.85 % |
|
LifescienceIC Analysis of the applications and added value of semiconductor devices in life sciences |
May 2006 | £2230 | 17.85 % |
|
Innovations in Bioinformatics Emerging Tools for Drug Discovery and Development |
January 2008 | £1995 | 16.45 % |
|
Indian Bioinformatics Industry |
April 2004 | £550 | 15.5 % |
|
Preventive Healthcare Technologies, Products and Markets |
October 2009 | £3205 | 15.05 % |
|
Market for Bioengineered Protein Drugs; The |
January 2007 | £2885 | 15 % |
|
Bioinformatics Technical Status and Market Prospects |
August 2005 | £2885 | 14.7 % |
|
Applied Biosystems Group |
December 2006 | £200 | 14 % |
|
Correlogic Systems, Inc. Product Pipeline Analysis |
August 2008 | £495 | 13.65 % |
|
Global Pharmaceutical Market Dynamics and Trends through 2016 |
September 2009 | £990 | 13.5 % |
|
Biotechnology Instrumentation International Market Trends |
November 2009 | £1980 | 13.5 % |
|
The Future of Metabolomics Building competitive advantage in drug discovery, clinical development and diagnostics |
August 2006 | £1495 | 13.5 % |
|
Biotech 2010 |
June 2006 | £2885 | 12.95 % |
|
Understanding the Global Biotech Industry The New 'Engine' of the Global Economy |
January 2009 | £395 | 12.6 % |
|
Cardiac Marker Diagnostic Testing Markets |
May 2008 | £2245 | 12.6 % |
|
Biotechnology in Australia IBISWorld Industry Report |
April 2009 | £390 | 12.5 % |
|
Future of BioSciences; The Four Scenarios for 2020 and Their Implications for Human Healthcare |
June 2006 | £990 | 12 % |
|
Pharmaceutical Biotechnology: Fundamentals and Applications Third Edition |
October 2007 | £115 | 11.9 % |
|
Emerging Applications and Architecture for High Performance Computing in the Life Sciences |
March 2005 | £1945 | 11.55 % |
|
Drug Delivery: Principles and Applications |
May 2005 | £61.5 | 11.5 % |
|
Molecular Diagnostics in Cancer Testing |
December 2009 | £2245 | 11.5 % |
|
Protein Microarrays: Technology Adoption & Utilization Technology Adoption & Utilization |
September 2005 | £2970 | 11.2 % |
|
Drug Discovery Technologies A Global Update of Market Trends & Opportunities |
November 2009 | £1980 | 10.5 % |
|
Bioinformatics Report The forecasts and future of the market 2006-2011 |
October 2006 | £1499 | 10.5 % |
|
Biomarkers Technologies, Markets and Companies |
March 2010 | £2970 | 10.5 % |
|
IT Software Tools for Life Science and Drug Discovery Bioscience, Biotechnology, Pharmaceutical Company and Institute's IT Software Tools, Strategy, and WW Market Outlook |
June 2009 | £1515 | 10.15 % |
|
Biochips Industry forecasts for 2012 & 2017 |
October 2008 | £3040 | 10.15 % |
|
Drug Repositioning A market analysis |
March 2006 | £1095 | 10.15 % |
|
Cancer Biomarkers: Players, products and prospects (Volume I) |
August 2008 | £595 | 10.15 % |
|
Cancer Therapies Global Market Opportunities |
November 2009 | £1980 | 10 % |
|
Burger's Medicinal Chemistry and Drug Discovery 6 Volume Set |
March 2003 | £1730 | 10 % |
|
2007 The Worldwide Biochip & Equipment Market |
August 2006 | £1185 | 10 % |
|
200 China-based Best CROs and CMOs |
March 2009 | £990 | 9.8 % |
|
Companion Biomarkers in Drug Development |
April 2009 | £2245 | 9.8 % |
|
Business Development: Accelerating the Deal |
May 2008 | £5080 | 9.5 % |
|
Toxicology and Pharmacology Outsourcing, History, Process and Regulation; Technical, Political and Economic Challenges |
January 2009 | £595 | 9.45 % |
|
Pharmacogenomics: The Search for Individualized Therapies |
April 2002 | £65 | 9.45 % |
|
Cancer, CNS & Cardiovascular Biomarkers: Players, products and prospects |
August 2008 | £1495 | 9.45 % |
|
Top 100 Best Pharma Outsourcing Service Providers in China and India |
July 2009 | £625 | 9.1 % |
|
Invitrogen Corporation - SWOT Analysis |
November 2008 | £44 | 9 % |
|
Invitrogen Corporation SWOT Analysis |
November 2008 | £44 | 9 % |
|
Three Alternative Scenarios Of The Future In Vitro Diagnostics Market 2007-2016 |
January 2008 | £7795 | 8.75 % |
|
CombiMatrix Corporation - Financial and Strategic Analysis Review |
June 2009 | £83 | 8.5 % |
|
Top Ten World's Leading Animal Health Companies |
October 2009 | £7595 | 8.5 % |
|
Personalized Medicine Scientific & Commercial Aspects |
March 2010 | £2640 | 8.4 % |
|
Bioinformatics Opportunities Business models, trends and future challenges |
May 2004 | £2500 | 8.4 % |
|
Biomarkers: The Future of Next-Generation Drug R&D |
September 2008 | £1715 | 8.05 % |
|
Animal Biotechnology Technologies, Markets and Companies |
March 2010 | £1650 | 8.05 % |
|
Translational Medicine In Biopharmaceutical R&d Enabling R&d Optimization And Early Detection Of Potential Failures |
October 2007 | £1495 | 7.7 % |
|
CytoCore, Inc. Product Pipeline Analysis |
August 2008 | £495 | 7.7 % |
|
Biomarkers, Tests and Trends for Drug R&D |
February 2010 | £1450 | 7.7 % |
|
Bioinformatics Markets Strategies, Business Models and Trends for the Future |
March 2009 | £2245 | 7.35 % |
|
Genomics World Markets |
May 2008 | £2245 | 7 % |
|
Therapeutic Drug Market for Acne Sector Snapshot |
May 2006 | £330 | 7 % |
|
Multiplex Assays Evolving Technologies, Applications and Future Directions |
December 2009 | £2475 | 7 % |
|
Next-Generation Nutraceuticals Food and pharma convergence in disease prevention and personalized nutrition |
December 2006 | £1495 | 6.65 % |
|
Biomarker Technology Platforms for Cancer Diagnoses and Therapies |
April 2008 | £2245 | 6.65 % |
|
Understanding Genomics and Global Health Impacts The Study of Disease at the Cellular and Molecular Level |
January 2009 | £460 | 6.65 % |
|
Sanofi-Aventis Deals Partneringdesk briefing |
July 2005 | £215 | 6.5 % |
|
Biomarkers The Expanding Global Market |
November 2007 | £3205 | 6.3 % |
|
Comprehensive Analysis of R&D and Commercialization for Related Biotechnologies from Non-Biotechnology/Non-Pharmaceutical Companies 100 |
February 2007 | £985 | 6 % |
|
Emerging Opportunities in Cancer Nanomedicine |
August 2006 | £995 | 6 % |
|
Systems Biology A Disruptive Technology |
May 2008 | £745 | 5.95 % |
|
Drug Targets for Breast Cancer |
January 2006 | £1095 | 5.95 % |
|
CNS Biomarkers: Players, products and prospects (Volume II) |
August 2008 | £595 | 5.6 % |
|
Complete Guide to the Diagnostic Market 2007-2012 |
January 2007 | £1600 | 5.6 % |
|
Cancer Diagnostic Testing World Markets |
April 2008 | £2245 | 5.6 % |
|
Microarray Markets |
September 2008 | £1320 | 5.25 % |
|
United Kingdom in Vitro Diagnostics Investment Opportunities Analysis and Forecasts to 2015 |
April 2009 | £1650 | 5.25 % |
|
Cardiovascular Biomarkers: Players, products and prospects (Volume III) |
August 2008 | £595 | 5.25 % |
|
Spectrometers and Spectrophoto/Fluorometers Global Market Trends |
November 2009 | £1980 | 5.25 % |
|
Global Medical Markets for Nanoscale Materials and Devices |
January 2008 | £3205 | 5.25 % |
|
Drug Discovery Handbook |
July 2005 | £94.5 | 5.25 % |
|
The Cancer Market Outlook To 2014 Competitive landscape, market size, pipeline analysis and growth opportunities |
January 2010 | £3835 | 5 % |
|
Drug Approval Trends at the FDA and EMEA Process Improvements, Heightened Scrutiny and Industry Response |
April 2008 | £1995 | 5 % |
|
Alzheimer's disease New Drugs, Markets and Companies |
October 2009 | £1980 | 4.9 % |
|
Electrophoresis Equipment & Supplies A World Market Review |
November 2009 | £1980 | 4.9 % |
|
China in Vitro Diagnostics Investment Opportunities Analysis and Forecasts to 2015 |
April 2009 | £1650 | 4.9 % |
|
Blood-Brain Barrier Bridging Options for Drug Discovery and Development |
May 2008 | £745 | 4.9 % |
|
Alzheimer Disease New Drugs, Markets and Companies |
May 2009 | £1850 | 4.9 % |
|
Alzheimer's disease New drugs, markets and companies |
December 2008 | £1980 | 4.9 % |
|
Nanomedicine 2006-2011 |
June 2006 | £1499 | 4.9 % |
|
Drug Delivery Systems US Market Outlook, Advances for Pharma, Biotech & Medical Devices |
September 2006 | £1515 | 4.55 % |
|
Companion Diagnostics in Personalized Medicine and Cancer Therapy |
April 2008 | £2245 | 4.55 % |
|
Alzheimer's Disease New Drugs, Markets and Companies |
October 2009 | £1980 | 4.55 % |
|
Hplc Systems & Accessories A World Market Review |
November 2009 | £1980 | 4.55 % |
|
Alzheimer's disease |
March 2010 | £2115 | 4.55 % |
|
Biologic Imaging Reagents Technologies and Global Markets |
December 2008 | £3205 | 4.55 % |
|
Alzheimer's Disease New Drugs, Markets and Companies |
February 2010 | £2115 | 4.55 % |
|
Cancer Biomarkers Enhancing diagnostic, therapeutic and developmental strategies |
May 2006 | £1450 | 4.2 % |
|
Molecular Diagnostics A World Market Review |
November 2009 | £1980 | 4.2 % |
|
Biochips A Global Update of Market Trends & Opportunities |
November 2009 | £1980 | 4.2 % |
|
Veterinary diagnostics and equipment The global market |
January 2006 | £795 | 4.2 % |
|
Decoding Big Pharma's R&D Strategy in Oncology |
September 2007 | £1755 | 4.2 % |
|
Nanotechnology in Life Science Applications |
October 2005 | £2885 | 3.85 % |
|
Central and Core Laboratories |
October 2007 | £995 | 3.85 % |
|
Biomarkers in Drug Discovery Optimizing Drug Discovery Timeline and Costs |
February 2010 | £2310 | 3.85 % |
|
Nanomaterials Markets by Type |
December 2005 | £2885 | 3.85 % |
|
Cell Therapy Technologies, Markets and Companies |
March 2010 | £3300 | 3.85 % |
|
Liquid Chromatography Markets (LC, HPLC and UHPLC) |
March 2003 | £2310 | 3.5 % |
|
DNA Sequencing Technologies, Markets and Companies |
March 2010 | £1190 | 3.5 % |
|
Comparison of Pharma Outsourcing between China and India |
July 2009 | £990 | 3.5 % |
|
Cytogenetics Technologies, Markets and Companies |
March 2010 | £1455 | 3.5 % |
|
Top 10 Biotech Companies Market Outlook, 2008-2023 |
December 2008 | £1499 | 3.5 % |
|
DNA Sequencing and PCR Markets |
July 2008 | £2245 | 3.5 % |
|
In Vitro Diagnostics Market Report & Analysis 2008-2023 |
June 2008 | £1499 | 3.15 % |
|
Drug Delivery to CNS |
March 2010 | £1850 | 3.15 % |
|
Molecular Diagnostics Major World Markets |
February 2007 | £2640 | 3.15 % |
|
Drug Delivery in Central Nervous System Diseases Technologies,Markets and Companies |
October 2009 | £1650 | 3.15 % |
|
Cell/Tissue Culture Supplies A Global Market Perspective |
November 2009 | £1980 | 3.15 % |
|
Drug Delivery to Central Nervous System Diseases Technologies, Markets and Companies |
February 2010 | £1850 | 3.15 % |
|
Live-Licensing & In-life Testing R&D Processes and Regulation for New Drugs, 2008-2020 |
January 2008 | £1499 | 3.15 % |
|
Gene Expression Profiling Markets |
January 2008 | £2640 | 3.15 % |
|
High-Growth Diagnostic Testing Markets |
November 2008 | £2245 | 2.8 % |
|
Personalized Medicine: Technologies and the Global Market |
July 2009 | £3205 | 2.8 % |
|
HighGrowth Diagnostic Markets |
November 2008 | £2245 | 2.8 % |
|
Global Biotech Market Analysis and Forecasts, 2008-2023 |
August 2008 | £1499 | 2.8 % |
|
Nanobiotechnology Applications, Markets and Companies |
March 2010 | £2970 | 2.45 % |
|
Molecular Diagnostics Markets |
September 2008 | £2245 | 2.45 % |
|
Drug Delivery in Cancer Technologies, Markets and Companies |
March 2010 | £2310 | 2.45 % |
|
Clinical Trials Business; The |
August 2006 | £2885 | 2.45 % |
|
Pipeline Insight: Epilepsy Pipeline drugs struggle to outshine their marketed predecessors |
October 2006 | £3965 | 2.45 % |
|
The Market for In Vitro Toxicology Testing |
March 2007 | £3205 | 2.45 % |
|
Nanomedicine |
July 2009 | £2610 | 2.1 % |
|
Nitric Oxide Therapeutics, Markets and Companies |
March 2010 | £1850 | 2.1 % |
|
Protein Therapeutics Market; The The Science and Business of a Growing Sector |
June 2006 | £2575 | 1.75 % |
|
Neuroprotection Drugs, Markets and Companies |
March 2010 | £2970 | 1.4 % |
